Greek study asks: does Iron-Control drug improve daily life for blood disorder patients?
Disease control
Not yet recruiting
This study aims to understand how a medication called deferasirox affects the daily life and well-being of adults in Greece with thalassemia and iron overload. Researchers will observe 150 patients who are already taking this medication as part of their standard care. They will u…
Sponsor: Elpen Pharmaceutical Co. Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC